CD274 and autoimmune thrombocytopenic purpura: Consistent with this finding, PD-L1-Fc can also mitigate the pathogenesis of immune thrombocytopenia (ITP) by increasing T-cell apoptosis and by suppressing T-cell activation and proliferation and cytokine (IFN-γ, IL-2) production (102).